Header Logo

Connection

Lori Sakoda to Risk Assessment

This is a "connection" page, showing publications Lori Sakoda has written about Risk Assessment.
Connection Strength

0.390
  1. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. Am J Hum Genet. 2020 09 03; 107(3):432-444.
    View in: PubMed
    Score: 0.133
  2. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2002 Jan; 11(1):51-7.
    View in: PubMed
    Score: 0.037
  3. Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants. J Natl Cancer Inst. 2021 01 04; 113(1):38-47.
    View in: PubMed
    Score: 0.034
  4. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.033
  5. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
    View in: PubMed
    Score: 0.033
  6. Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women. Cancer Epidemiol Biomarkers Prev. 2020 05; 29(5):1039-1048.
    View in: PubMed
    Score: 0.032
  7. Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):860-870.
    View in: PubMed
    Score: 0.032
  8. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Gastroenterology. 2020 04; 158(5):1300-1312.e20.
    View in: PubMed
    Score: 0.032
  9. Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China. Int J Cancer. 2006 Jun 15; 118(12):3089-94.
    View in: PubMed
    Score: 0.012
  10. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2929-35.
    View in: PubMed
    Score: 0.012

© 2024 Kaiser Permanente